March 16, 2021
Ann Romaker, MD, of the Division of Pulmonary, Critical Care and Sleep Medicine is widely quoted in an article on Livestrong.com about the potential health challenges posed by snoring. She says there is evidence that loud snoring could lead to stroke.
March 22, 2021
Timothy Pritts, MD, PhD, chief of the section of general surgery and vice chair of clinical operations at the UC College of Medicine, weighs in on new study about early-career acute care surgeons and the need for mentorship to improve patient outcomes.
March 24, 2021
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was one of the sources quoted in an article for Reuters Health on a study showing that in patients with moderate-severe COVID-19, recombinant super-compound interferon plus baseline antivirals was associated with a shorter time to clinical improvement than the same regimen using traditional interferon-alpha in an exploratory trial in China. Fichtenbaum said a lot more data and proof is needed before he would use this. And the lack of a control group that got just standard of care is a big weakness of this study.
March 15, 2021
University of Cincinnati researchers say for the first time they have a visual correlation between the severity of COVID-19 in the lungs and the effect on patients' brains, WVXU-FM reports.
March 29, 2021
Jonathan Bernstein, MD, University of Cincinnati allergies, speaks with Reuters Health about a new study suggesting hormone replacement therapy increasing the risk of severe asthma in asthmatic women.
December 4, 2020
Margaret Powers-Fletcher, MD, of the UC Division of Infectious Diseases was interviewed by several media outlets about the COMPASS study she is leading.
December 1, 2020
Donald Lynch, MD, assistant professor of cardiovascular health and disease in the University of Cincinnati College of Medicine, is partnering with researchers in Missouri and Georgia to create a smartphone app that delivers COVID-19 information tailored to Black communities.
December 1, 2020
Jarelle Marshall, the first patient dosed in the UC/UC Health Moderna COVID-19 vaccine trial was interviewed by CNN about his experience.
December 2, 2020
UC is joining a nationwide study to examine the impact of COVID-19 on communities across the United States. The Community Prevalence of SARS-CoV-2 Study (COMPASS) is part of the efforts by the COVID-19 Prevention Network launched by the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health (NIH).
December 1, 2020
Northern Kentucky businessman Carl Fox is taking part in UC's Trailblazer study and is telling his story to WCPO-TV, Channel 9. The TRAILBLAZER study aims to change the parts of a patient’s white blood cells that HIV latches onto, and is led by Dr. Carl Fichtenbaum, a professor in the Division of Infectious Diseases in the Department of Internal Medicine at the University of Cincinnati College of Medicine.